Search alternatives:
web decrease » we decrease (Expand Search), teer decrease (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a web » _ web (Expand Search)
web decrease » we decrease (Expand Search), teer decrease (Expand Search), step decrease (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a web » _ web (Expand Search)
-
5901
Identification of +TIPs required for MT plus-end targeting of dynein-dynactin in the <i>C</i>. <i>elegans</i> early embryo.
Published 2017“…<b>(C)</b> Cortical confocal section in one-cell embryos co-expressing GFP::p50<sup>DNC-2</sup> and EBP-2::mKate2, showing that depletion of dynein intermediate chain<sup>DYCI-1</sup> or LIS-1 decreases dynactin levels at MT plus ends. …”
-
5902
The Strong <i>In Vivo</i> Anti-Tumor Effect of the UIC2 Monoclonal Antibody Is the Combined Result of Pgp Inhibition and Antibody Dependent Cell-Mediated Cytotoxicity
Published 2014“…However, this inhibition is partial, since UIC2 binds only to 10–40% of cell surface Pgps, while the rest becomes accessible to this antibody only in the presence of certain substrates or modulators (e.g. cyclosporine A (CsA)). The combined addition of UIC2 and 10 times lower concentrations of CsA than what is necessary for Pgp inhibition when the modulator is applied alone, decreased the EC<sub>50</sub> of doxorubicin (DOX) in KB-V1 (Pgp<sup>+</sup>) cells <i>in vitro</i> almost to the level of KB-3-1 (Pgp<sup>-</sup>) cells. …”
-
5903
-
5904
GRADE judgements.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
5905
The data of meta-analysis.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
5906
Risk of bias.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
5907
Overall risk of bias assessment.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
5908
Funnel plot of VO<sub>2Peak</sub> inclusion studies.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
5909
Analysis of subgroups.
Published 2025“…Normally presenting with symptoms such as dyspnea, decreased exercise tolerance, decreased maximal heart rate, and decreased arterial oxygen saturation. …”
-
5910
Screening for cell culture grown HCV genotype 1a (clone H77) infectivity in the presence of vaccine sera.
Published 2013“…Neutralizing sera are those which display ≥50% decrease in FFU at a dilution of ≥1∶20 (panel A). …”
-
5911
Disorder–Order Structural Transformation in Electron-Poor Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> Driven by Chemical Bonding Optimization
Published 2013“…Single-crystal X-ray diffraction analyses revealed that Sr<sub>3</sub>Au<sub>8</sub>Sn<sub>3</sub> has a La<sub>3</sub>Al<sub>11</sub>-type <i>Immm</i> structure (<i>a</i> = 4.6767(8) Å, <i>b</i> = 9.646(2) Å, <i>c</i> = 14.170(2) Å, <i>Z</i> = 2) if annealed at 550 °C and above but a Ca<sub>3</sub>Au<sub>8</sub>Ge<sub>3</sub>-type structure (<i>Pnnm</i>, <i>a</i> = 9.6082(8) Å, <i>b</i> = 14.171(1) Å, <i>c</i> = 4.6719(4) Å, <i>Z</i> = 2) if annealed at 400 °C. …”
-
5912
-
5913
Engineering of p150<sup>DNC-1</sup> mutants for functional characterization of dynactin's MT binding activity.
Published 2017“…<p><b>(A)</b> Cartoon of the dynactin complex and its interaction with MTs and end-binding protein (EB). …”
-
5914
Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
Published 2018“…Objective: Systematic review of randomized clinical trials of statin use to treat children and adolescents with dyslipidemia secondary to obesity. Methods: We performed a search in PubMed, EMBASE, Bireme, Web of Science, Cochrane Library, SciELO, and LILACS for data to evaluate the effect of statins on: improvement of surrogate markers of coronary artery disease in clinical outcomes of adulthood; increased serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipropotein B (APOB); and decreased serum levels of high-density lipoprotein cholesterol (HDL-C) from inception to February 2016. …”
-
5915
Secondary Dyslipidemia In Obese Children - Is There Evidence For Pharmacological Treatment?
Published 2018“…Objective: Systematic review of randomized clinical trials of statin use to treat children and adolescents with dyslipidemia secondary to obesity. Methods: We performed a search in PubMed, EMBASE, Bireme, Web of Science, Cochrane Library, SciELO, and LILACS for data to evaluate the effect of statins on: improvement of surrogate markers of coronary artery disease in clinical outcomes of adulthood; increased serum levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and apolipropotein B (APOB); and decreased serum levels of high-density lipoprotein cholesterol (HDL-C) from inception to February 2016. …”
-
5916
-
5917
Image_1_Eph-ephrin Signaling Affects Eye Lens Fiber Cell Intracellular Voltage and Membrane Conductance.TIF
Published 2021“…Immunostaining revealed changes in connexin 50 (Cx50) subcellular localization in EphA2<sup>–/–</sup> peripheral lens fibers and alteration in aquaporin 0 (Aqp0) staining patterns in ephrin-A5<sup>–/–</sup> and EphA2<sup>–/–</sup> inner mature fiber cells. …”
-
5918
-
5919
Morphological schematic diagram of <i>A</i>. <i>Adenophora</i>.
Published 2024“…The phytochemical variability of the extracts was also studied. The LC<sub>50</sub> value of the <i>A</i>. <i>adenophora</i> extract against <i>L</i>. …”
-
5920